hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-05-05小儿冻伤
- 2022-04-202013年的国际抗癫痫联合会抗癫痫药使用指南
- 2022-04-13预测癫痫患者再入院风险
- 2022-04-12罕见病例:自发性颞极性扩张伴癫痫发作
- 2022-04-11癫痫发作对中风患者静脉溶栓的长期转移有效
- 2022-04-11月经性癫痫患者妊娠期癫痫控制更好
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- 月经性癫痫患者妊娠期癫痫控制更好
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 癫痫治疗障碍仍难以克服
- 上海率先探索异地就医门诊费直接结算
- 抗癫痫药物预防新发癫痫:任重而道远
- FDA批准Aptiom用于治疗患者癫痫发作
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 癫痫患者如何克服忘记吃药的问题?
- 癫痫治疗 中医治疗癫痫不用担心
- 癫痫的治疗方法 中医拔罐治疗癫痫的小方法(2)
- 2013国际抗癫痫联合会抗癫痫药用指南
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 癫痫猝死:凶手是谁?
- 2015 神经系统疾病诊疗进展
- 睡觉时突然抽搐 新生儿睡觉抽搐怎么办?
- UCB的Vimpat癫痫新适应症在美国获批
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- 泡温泉时不能忽视的事情
- 癫痫患者手术评估新型工具
- 癫痫定位新方法:无框架立体定向脑电图技术
- 黑芝麻的营养价值 吃黑芝麻的好处
- 心理百科:春节期间小心疾病
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 癫痫治愈费用
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 该委员会:新型冠状病毒感染肺炎患者个人负担费用实行财政兜底
- 索契频发癫痫症 索契为何频发癫痫症
- 癫痫病的饮食需要提醒什么
- 癫痫患者的饮食需注意哪些问题
- 癫痫病的前期有什么征状
- 引发羊癫疯的病因是什么
- 全「利」管控 升级保护——利必通®分散片中国上市会
- 上海率先探索为了将就医门诊费用直接结算
- 20130318东南食来运转预告片:猪血豆腐汤的做法
- 迈瑞、瑞普等大行业重点布局,新瑞鹏融资额领跑,宠物医疗迎来爆发丨2020年度盘点
- 40多岁的妇女经常随地脱裤子解气喘,竟是因为得了这个病!
- 疗法癫痫病比较好的方法是什么
- 小儿癫痫病症状平庸